Overall Score

Strengths

Healthy liquidity with a current ratio of 2.69 and quick ratio of 1.76.

Moderate leverage with debt-to-equity of 0.29 and net debt to EBITDA of 1.12.

Solid gross margin of 45.3% and operating margin of 13.2%.

Interest coverage remains adequate at 8.85x.

Weaknesses

Valuation remains elevated at 45.3x earnings and 61.3x free cash flow.

Cash conversion is weak, with free cash flow yield at 1.6% and operating cash flow margin at 8.7%.

Working capital efficiency is pressured by 103.6 days sales outstanding and a 199.5-day cash conversion cycle.

Return on capital remains modest, with ROIC at 6.9% and ROE at 8.5%.

Opportunities

Improving cash generation could support a rerating if free cash flow margins expand.

Operational efficiency gains may be available given the current 13.2% operating margin and 45.3% gross margin.

Balance sheet flexibility leaves room for selective capital deployment or acquisitions.

Threats

High valuation leaves the stock vulnerable if growth or margins disappoint.

Long cash conversion cycle and elevated inventory days could keep working capital tied up.

Profitability is still only mid-single-digit on a net basis, limiting downside protection.